These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current status of capecitabine in the treatment of colorectal cancer. Rothenberg ML Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):16-22. PubMed ID: 12520635 [TBL] [Abstract][Full Text] [Related]
3. Capecitabine/irinotecan in colorectal cancer: European early-phase data and planned trials. Kerr D Oncology (Williston Park); 2002 Dec; 16(12 Suppl No 14):12-5. PubMed ID: 12520634 [TBL] [Abstract][Full Text] [Related]
5. Cetuximab plus XELIRI or XELOX for first-line therapy of metastatic colorectal cancer. Moosmann N; Heinemann V Clin Colorectal Cancer; 2008 Mar; 7(2):110-7. PubMed ID: 18501070 [TBL] [Abstract][Full Text] [Related]
6. Optimizing the use of irinotecan in colorectal cancer. Cunningham D; Maroun J; Vanhoefer U; Van Cutsem E Oncologist; 2001; 6 Suppl 4():17-23. PubMed ID: 11585970 [TBL] [Abstract][Full Text] [Related]
7. Comparing safety and efficacy of first-line irinotecan/fluoropyrimidine combinations in elderly versus nonelderly patients with metastatic colorectal cancer: findings from the bolus, infusional, or capecitabine with camptostar-celecoxib study. Jackson NA; Barrueco J; Soufi-Mahjoubi R; Marshall J; Mitchell E; Zhang X; Meyerhardt J Cancer; 2009 Jun; 115(12):2617-29. PubMed ID: 19382200 [TBL] [Abstract][Full Text] [Related]
8. Differences in efficacy and safety between capecitabine and infusional 5-fluorouracil when combined with irinotecan for the treatment of metastatic colorectal cancer. Montagnani F; Chiriatti A; Licitra S; Aliberti C; Fiorentini G Clin Colorectal Cancer; 2010 Oct; 9(4):243-7. PubMed ID: 20920997 [TBL] [Abstract][Full Text] [Related]
9. Oral capecitabine: bridging the Atlantic divide in colon cancer treatment. Van Cutsem E; Verslype C; Tejpar S Semin Oncol; 2005 Feb; 32(1):43-51. PubMed ID: 15726505 [TBL] [Abstract][Full Text] [Related]
10. Dosing considerations for capecitabine-irinotecan regimens in the treatment of metastatic and/or locally advanced colorectal cancer. Cartwright T; McCollum D; Boehm KA Am J Clin Oncol; 2010 Jun; 33(3):307-13. PubMed ID: 20375835 [TBL] [Abstract][Full Text] [Related]
11. Capecitabine: the new generation of fluoropyrimidines in colorectal cancer. Iqbal S; Lenz HJ Expert Rev Anticancer Ther; 2004 Dec; 4(6):947-55. PubMed ID: 15606325 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of combination chemotherapy with irinotecan (CPT-11) plus capecitabine in patients with metastatic or advanced colorectal carcinoma--a dual-centre phase II study: the MAC-6. Choi CK; Chan RT; Tung SY; Lui L; Siu S; Au GK; Ho JW; Law WL Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):168-75. PubMed ID: 18155454 [TBL] [Abstract][Full Text] [Related]
13. Treatment of colorectal cancer metastasis: the role of chemotherapy. Xiong HQ; Ajani JA Cancer Metastasis Rev; 2004; 23(1-2):145-63. PubMed ID: 15000155 [TBL] [Abstract][Full Text] [Related]
14. Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancer. Gennatas C; Michalaki V; Gennatas S; Papalambros E Anticancer Res; 2008; 28(3B):1923-6. PubMed ID: 18630482 [TBL] [Abstract][Full Text] [Related]
15. Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy. Koukourakis G; Kouloulias V; Zacharias G; Koukourakis M J BUON; 2010; 15(4):652-9. PubMed ID: 21229625 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis comparing the safety and efficacy of metastatic colorectal cancer treatment regimens, capecitabine plus irinotecan (CAPIRI) and 5-fluorouracil/leucovorin plus irinotecan (FOLFIRI). Ding HH; Wu WD; Jiang T; Cao J; Ji ZY; Jin JH; Wang JJ; Song WF; Wang LW Tumour Biol; 2015 May; 36(5):3361-9. PubMed ID: 25534239 [TBL] [Abstract][Full Text] [Related]
17. Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results. Patt YZ; Lee FC; Liebmann JE; Diamandidis D; Eckhardt SG; Javle M; Justice GR; Keiser W; Salvatore JR; Bexon A; Lin E Am J Clin Oncol; 2007 Aug; 30(4):350-7. PubMed ID: 17762434 [TBL] [Abstract][Full Text] [Related]
18. The combination of capecitabine and oxaliplatin in metastatic colorectal cancer. Clin Colorectal Cancer; 2003 Feb; 2(4):205-9. PubMed ID: 12620138 [No Abstract] [Full Text] [Related]
19. The role of new agents in the treatment of colorectal cancer. Folprecht G; Köhne CH Oncology; 2004; 66(1):1-17. PubMed ID: 15031593 [TBL] [Abstract][Full Text] [Related]
20. Capecitabine plus irinotecan versus 5-FU/leucovorin plus irinotecan in the treatment of colorectal cancer: a meta-analysis. Guo Y; Shi M; Shen X; Yang C; Yang L; Zhang J Clin Colorectal Cancer; 2014 Jun; 13(2):110-8. PubMed ID: 24461997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]